Abstract:The development of a highly efficient, low-toxicity, ultrasmall ferrite nanoparticle-based T-1 contrast agent for high-resolution magnetic resonance imaging (MRI) is highly desirable. However, the correlations between the chemical compositions, in vitro T-1 relaxivities, in vivo nano-bio interactions and toxicities remain unclear, which has been a challenge in optimizing the in vivo T-1 contrast efficacy. Methods: Ultrasmall (3 nm) manganese ferrite nanoparticles (MnxFe3-xO4) with different doping concentrations of the manganese ions (x = 0.32, 0.37, 0.75, 1, 1.23 and 1.57) were used as a model system to investigate the composition-dependence of the in vivo T-1 contrast efficacy. The efficacy of liver-specific contrast-enhanced MRI was assessed through systematic multiple factor analysis, which included the in vitro T1 relaxivity, in vivo MRI contrast enhancement, pharmacokinetic profiles (blood half-life time, biodistribution) and biosafety evaluations (in vitro cytotoxicity testing, in vivo blood routine examination, in vivo blood biochemistry testing and H&E staining to examine the liver). Results: With increasing Mn doping, the T-1 relaxivities initially increased to their highest value of 10.35 mM(-1)s(-1), which was obtained for Mn0.75Fe2.25O4, and then the values decreased to 7.64 m M(-1)s(-1), which was obtained for the Mn1.57Fe1.43O4 nanoparticles. Nearly linear increases in the in vivo MRI signals (Delta SNR) and biodistributions (accumulation in the liver) of the MnxFe3-xO4 nanoparticles were observed for increasing levels of Mn doping. However, both the in vitro and in vivo biosafety evaluations suggested that MnxFe3-xO4 nanoparticles with high Mn-doping levels (x > 1) can induce significant toxicity. Conclusion: The systematic multiple factor assessment indicated that the MnxFe3-xO4 (x = 0.75-1) nanoparticles were the optimal T-1 contrast agents with higher in vivo efficacies for liver-specific MRI than those of the other compositions of the MnxFe3-xO4 nanoparticles. Our work provides insight into the optimization of ultrasmall ferrite nanoparticle-based T-1 contrast agents by tuning their compositions and promotes the translation of these ultrasmall ferrite nanoparticles for clinical use of high-performance contrast-enhanced MRI.

Ultrasmall Pegylated Mnxfe3-Xo4 (X=0-0.34) Nanoparticles: Effects Of Mn(Ii) Doping On T-1-And T-2-Weighted Magnetic Resonance Imaging

Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their In Vivo T 1 Contrast Efficacy.

Composition Tunable Manganese Ferrite Nanoparticles for Optimized T-2 Contrast Ability

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Controlled Synthesis Of Mnfe2o4 Nanoparticles And Gd Complex-Based Nanocomposites As Tunable And Enhanced T-1/T-2-Weighted Mri Contrast Agents

Ultrasmall Ferrite Nanoparticles Synthesized Via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent.

Facile Synthesis of Ultrasmall MnFe2O4 Nanoparticles with High Saturation Magnetization for Magnetic Resonance Imaging

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

PEGylation of MnO Nanoparticles Via Catechol–mn Chelation to Improving T1‐weighted Magnetic Resonance Imaging Application

Mn(ii) Chelate-Coated Superparamagnetic Iron Oxide Nanocrystals As High-Efficiency Magnetic Resonance Imaging Contrast Agents

Coating Engineering of Mnfe2o4 Nanoparticles with Superhigh T-2 Relaxivity and Efficient Cellular Uptake for Highly Sensitive Magnetic Resonance Imaging

Synthesis and characterization of PEG-coated Zn$_{0.3}$Mn$_x$Fe$_{2.7-x}$O$_4$ nanoparticles as the dual T1/T2-weighted MRI contrast agent

Precisely Tuning the Contrast Properties of ZnxFe3–xO4 Nanoparticles in Magnetic Resonance Imaging by Controlling Their Doping Content and Size

A Cheap and Facile Route to Synthesize Monodisperse Magnetic Nanocrystals and Their Application As Mri Agents

Role Of Mn2+ Doping In The Preparation Of Core-Shell Structured Fe3o4@Upconversion Nanoparticles And Their Applications In T-1/T-2-Weighted Magnetic Resonance Imaging, Upconversion Luminescent Imaging And Near-Infrared Activated Photodynamic Therapy

Surface Manganese Substitution in Magnetite Nanocrystals Enhancest1contrast Ability by Increasing Electron Spin Relaxation

Role of Mn2+ Doping in the Preparation of Core-Shell Structured Fe3O4@upconversion Nanoparticles and Their Applications in T1/T2-Weighted Magnetic Resonance Imaging, Upconversion Luminescent Imaging and Near-Infrared Activated Photodynamic Therapy

Antifouling Manganese Oxide Nanoparticles: Synthesis, Characterization, and Applications for Enhanced MR Imaging of Tumors

Preparation and Growth Orientation Modulation of Mn0.6Zn0.4Fe2O4 Nanoparticles As MRI Contrast Agents

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging

Surface Morphology and Payload Synergistically Caused an Enhancement of the Longitudinal Relaxivity of a Mn3O4/PtOx Nanocomposite for Magnetic Resonance Tumor Imaging.